Latest News
NexMed shares plunge on move to nix product filing
Boston Globe, The | 2 hours 19 minutes ago
NEW YORK—Shares of drug developer NexMed Inc. plunged Wednesday after the company said its development partner, Swiss pharmaceutical company Novartis AG, will not ask for regulatory approval of a developing nail fungus treatment.... (more)
Movers roundup: NexMed, Bristol-Myers Squibb
Boston Globe, The | 2 hours 19 minutes ago
Among the stock activity stories for Wednesday, Aug. 27, from AP Financial News:... (more)
BSNL unveils 3G services in Pune
Business Standard (India) | 6 hours 17 minutes ago
BSNL unveils 3G services in PuneKaustubh Kulkarni / Pune August 28, 2008, 0:42 IST... (more)
DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology - Press Releases: PR Newswire: Utilities - SunHerald.com
Sun Herald (Biloxi-Gulfport, Miss.), The | 6 hours 39 minutes ago
"We are very pleased with the progress and speed with which Pain Therapeutics and King Pharmaceuticals are developing this series of four opioids licensed from us," stated James Brown, Chief Executive Officer of DURECT. "This marks another milestone for our ORADUR technology as a versatile platform that provides for the controlled delivery of pharmaceuticals that are commonly abused."... (more)
Alkermes slides on diabetes drug concerns
Boston Globe, The | 8 hours 18 minutes ago
NEW YORK—Shares of Alkermes Inc. declined Wednesday as investors weighed potential bad news for one drug Alkermes helped develop with good news for another.... (more)
Waters rise as recovery funds flow | floridatoday.com | FLORIDA TODAY
Florida Today (Melbourne) | 19 hours 40 minutes ago
Flood victims can apply for federal money to repair damages from Tropical Storm Fay under a decision announced Tuesday by the Federal Emergency Management Agency.... (more)
Waters develops PoraPak Rxn cartridges for medicinal chemistry labs
Pharmabiz.com (India) | 22 hours 52 minutes ago
Waters has new addition to its line of sample preparation products. Known as PoraPak Rxn Cartridges, these are single-use, syringe-barrel cartridges that offer medicinal chemists an effective and simpler method of isolating target compounds in synthetic reaction mixtures. PoraPak Rxn Cartridges are a cost-effective alternative to flash chromatography or liquid/liquid extraction for fractionating reaction mixtures, taking much of the complexity out of the process and consuming significantly le...... (more)
Varian wins RapidArc install in N.Y.
HealthImaging.com | 1 day 11 hours 39 minutes ago
Clinicians from the image-guided radiation therapy program at Community Care Physicians in Latham N.Y., have commenced treating cancer patients using RapidArc radiotherapy technology from Varian Medical Systems. RapidArc treatments spare healthy tissue and other vital organs in the body by adapting to the shape and size of a patient's tumor. These treatments can be completed more quickly than conventional intensity-modulated radiatio... (more)
Medicine -- South Florida Sun-Sentinel.com
Sun-Sentinel (Fort Lauderdale, Fla.) | 1 day 18 hours 54 minutes ago
Shares of Miami-based Noven Pharmaceuticals Inc. shares fell 2.8 percent in Nasdaq trading after voluntarily recalling drug-coated patches because of faulty paper backing. The 469,000 patches, sold by Shire Ltd. and manufactured by Noven, are being withdrawn because some users couldn't peel off the adhesive's paper backing. Shares closed at $12.33, down 35 cents.... (more)
Ohio.com - Game TwoWHITE SOX 4, OR...
Akron Beacon Journal (Ohio) | 1 day 19 hours ago
Big debate from SEC to Big Ten... (more)
Healthways shares plunge on weak 1Q guidance
Boston Globe, The | 2 days 8 hours 4 minutes ago
NEW YORK—Shares of Healthways Inc. plunged more than 20 percent Monday after the disease-management program administrator set first-quarter profit guidance below Wall Street forecasts because of contract losses and renegotiations.... (more)
Noven partner recalls ADHD drug lots over defect
Boston Globe, The | 2 days 10 hours 3 minutes ago
NEW YORK—Noven Pharmaceuticals Inc. said its partner Shire Ltd. is voluntarily recalling two lots of the attention deficit hyperactivity disorder drug patch Daytrana because of a problem with the patch liner.... (more)
Reynolds Plantation, home to superb golf, lives up to reputation
WorldGolf | 2 days 12 hours 21 minutes ago
By Tim McDonald, National Golf EditorWith five excellent golf courses, all superbly maintained, and all sorts of fun things to do for the family, the sprawling Reynolds Plantation golf resort is one of the best communities in Georgia golf and, possibly, the U.S.... (more)
Two lots of Noven and Shire ADHD patch recalled
International Herald Tribune | 2 days 12 hours 51 minutes ago
BOSTON: Noven Pharmaceuticals said on Monday that its marketing partner, Shire , is voluntarily recalling two batches of its skin patch to treat attention deficit hyperactivity disorder because of difficulties removing the release liner when the patch is peeled open.... (more)
Generex Bio inks Glucose RapidSpray distribution deal in Brazil
Pharmabiz.com (India) | 2 days 21 hours 27 minutes ago
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has entered into a product licensing and distribution agreement with ABP-Com rcio, Importa o E Exporta o Ltda for the registration, importation, marketing, distribution, and sale in Brazil of Glucose RapidSpray, the company's proprietary glucose buccal spray product. ABP is a specialized import/export organization headquartered in Brazil.... (more)
15 Stories | 
RSS Feed
Sign up for SNM SmartBrief
Companies in the news
- Alkermes Inc
- DURECT Corporation
- Generex Biotechnology Corporation
- Healthways Inc
- NexMed Inc.
- Noven Pharmaceuticals
- Pune
- Varian